Relationship of galectin-3 with obesity, IL-6, and CRP in women

Galectin-3 Participates in Cardiovascular Remodeling Associated With ObesityNovelty and Significance

(2015) Ernesto Martínez-Martínez et al.   HYPERTENSION

Vitamin D, inflammation, and relations to insulin resistance in premenopausal women with morbid obesity

(2015) Van T. Nguyen et al.   Obesity

Galectin-3 is independently associated with cardiovascular mortality in community-dwelling older adults without known cardiovascular disease: The Rancho Bernardo Study

(2014) Lori B. Daniels et al.   AMERICAN HEART JOURNAL

Galectin-3: A Modifiable Risk Factor in Heart Failure

(2014) Rudolf A. de Boer et al.   CARDIOVASCULAR DRUGS AND THERAPY

Serum galectin-3 levels in women with PCOS

(2014) H. Yilmaz et al.   JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION

High-Sensitivity C-Reactive Protein and Cardiovascular Disease

(2013) Omair Yousuf et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Adipose tissue-specific modulation of galectin expression in lean and obese mice: Evidence for regulatory function

(2013) Davina H. Rhodes et al.   Obesity

Increased Adiposity, Dysregulated Glucose Metabolism and Systemic Inflammation in Galectin-3 KO Mice

(2013) Jingbo Pang et al.   PLoS One

Galectin-3: its role in asthma and potential as an anti-inflammatory target

(2013) Peng Gao et al.   RESPIRATORY RESEARCH

Genetic and Pharmacological Inhibition of Galectin-3 Prevents Cardiac Remodeling by Interfering With Myocardial Fibrogenesis

(2012) Lili Yu et al.   Circulation-Heart Failure

Morbid obesity rates continue to rise rapidly in the United States

(2012) R Sturm et al.   INTERNATIONAL JOURNAL OF OBESITY

Galectin-3, a Marker of Cardiac Fibrosis, Predicts Incident Heart Failure in the Community

(2012) Jennifer E. Ho et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Immunological complications of obesity

(2012) Thirumala-Devi Kanneganti et al.   NATURE IMMUNOLOGY

Obesity, inflammation and the immune system

(2012) Fátima Pérez de Heredia et al.   PROCEEDINGS OF THE NUTRITION SOCIETY

Deficiency in Galectin-3 Promotes Hepatic Injury in CDAA Diet-Induced Nonalcoholic Fatty Liver Disease

(2012) Kazuhiro Nomoto et al.   TheScientificWorldJOURNAL

Obesity, leptin, and Alzheimer's disease

(2011) Edward B. Lee   Annals of the New York Academy of Sciences

Galectin-3 – A jack-of-all-trades in cancer

(2011) Anna U. Newlaczyl et al.   CANCER LETTERS

Elevated production of galectin-3 is correlated with juvenile idiopathic arthritis disease activity, severity, and progression

(2011) Mohamed Hesham Mohamed EZZAT et al.   International Journal of Rheumatic Diseases

The fibrosis marker galectin-3 and outcome in the general population

(2011) R. A. de Boer et al.   JOURNAL OF INTERNAL MEDICINE

Diabetes and pancreatic cancer

(2011) Donghui Li   MOLECULAR CARCINOGENESIS

Galectins: regulators of acute and chronic inflammation

(2010) Fu-Tong Liu et al.   Annals of the New York Academy of Sciences

Serum Galectin-3 Is Elevated in Obesity and Negatively Correlates with Glycosylated Hemoglobin in Type 2 Diabetes

(2010) Johanna Weigert et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Accelerated Lipid-Induced Atherogenesis in Galectin-3-Deficient Mice

(2009) Carla Iacobini et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Dynamics of galectin-3 in the nucleus and cytoplasm

(2009) Kevin C. Haudek et al.   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS

Adiponectin downregulates galectin-3 whose cellular form is elevated whereas its soluble form is reduced in type 2 diabetic monocytes

(2009) Markus Weber et al.   FEBS LETTERS

Galectins: structure, function and therapeutic potential

(2008) Ri-Yao Yang et al.   EXPERT REVIEWS IN MOLECULAR MEDICINE

A Role for galectin-3 in renal tissue damage triggered by ischemia and reperfusion injury

(2008) Ana Paula Fernandes Bertocchi et al.   TRANSPLANT INTERNATIONAL